Author name: nursfpxmassivedynamics

NURS FPX 8004 Assessment 3 Annotated Bibliography Student name Capella University NURS- FPX8004 Professor Name Submission Date NURS FPX 8004 Assessment 3 Annotated Bibliography Music Therapy (MT) is an evidence-based method to deal with the emotional and psychological distress of adult patients with cancer in the outpatient chemotherapy unit. An adverse effect of chemotherapy is the cycle of anxiety, fatigue, and distress that wors with each session. Emotional distress is primarily managed with medication; however, there is a lack of structured, non-pharmacological support (Executive Nurse, personal communication, April 15, 2026). The primary audience is adult patients with cancer who receive chemotherapy. Stakeholders consist of oncology nurses, oncologists, nurse practitioners, healthcare administrators, and patients and their families. The addition of music therapy to oncology services can be supportive and add a holistic, patient-centered approach to services. The PICOT framework of the project is as follows: Among outpatient chemotherapy staff of adult oncology patients (P), the addition of music therapy groups (I), versus no music therapy groups (C), what is the impact on anxiety and the state of well-being (O)? NURS FPX 8004 Assessment 3 Annotated Bibliography requires nursing students to evaluate current scholarly literature, summarize research findings, assess evidence quality, and connect research outcomes to a specific clinical practice problem using APA formatting. Problem Statement  At present, the continuous stressful side effects of outpatient oncology chemotherapy increase patients’ anxiety and overall low sense of well-being. It is hypothesized that the establishment of music therapy groups will decrease anxiety and improve patients’ sense of well-being during the outpatient chemotherapy process. Thesis Statement Anticipated emotional coping during the ongoing stressful chemotherapy sessions is expected to improve, as will the overall oncology service experience, with the establishment of music therapy groups. Search Strategy The author searched multiple electronic databases, including PubMed/MEDLINE, The Cochrane, and CINAHL, for literature on music therapy and oncology. Searches were restricted to articles published in 2023, 2024, and 2025, and available in English. Only peer-reviewed articles were included. Searches focused on the following terms and phrases: music therapy oncology; music therapy and anxiety; oncology non-pharmacologic; music therapy oncology group; oncology chemotherapy patient wellbeing. The initial search resulted in over 150 articles. Inclusion criteria focused on articles that addressed adult oncology patients, group music therapy, and the outcomes of anxiety and the associated psychological well-being. Articles that addressed pediatric patients, pharmacologic interventions, non-chemotherapy interventions, or duplicate publications were excluded. The author relied on the remaining eight publications to create an annotated bibliography. The remaining publications were randomized controlled trials, systematic reviews, and qualitative studies. All supported the author’s initiative to implement music therapy in outpatient oncology chemotherapy. Annotated Bibliography He, Y. L., Qian, C. N., Chen, J. Z., Chen, J. Y., Chen, K. J., Chen, Y. Y., Dong, X. T., Guan, N. H., Guo, Z. D., Hong, L., Huang, W., Jia, Y. B., Li, H. Y., Su, F. X., Li, S. R., Zhu, L. L., Li, Z. J., Leung, H. Y. A., Liang, Z. F., & Yuan, T. Z. (2026). CACA guidelines for music-based interventions in oncology. Holistic Integrative Oncology, 5(1), 45–67. https://doi.org/10.1007/s44178-025-00211-2 Research/QI: Research Design We incorporated an understanding of the available literature on music therapy in oncology as part of our research with the oncology context of the outpatient chemotherapy process. A literature review on the impact of music therapy on adult outpatient chemotherapy patients was completed. Published literature, systematic reviews, and clinical research were surveyed. The literature reported anxiety reduction and improvement in the reported well-being of patients receiving Structured Group Music Therapy. The study highlighted the necessity for adjunct non-pharmaceutical interventions to standard chemotherapy within the holistic care continuum. The study emphasized the use of music therapy in conventional oncology practice and contributed to the continuous quality improvement process. Hernandez, M. A., Cubeddu, L. X., & Paramo, J. C. (2026). Effects of music therapy in cancer patients undergoing infusion chemotherapy: A prospective cohort observational study. Supportive Care in Cancer, 34(4), 67–90. https://doi.org/10.1007/s00520-026-10560-x Research/QI: Research Design The effects of music therapy on oncology patients were studied using a retrospective cohort analysis of anxiety levels and overall wellness of adult patients receiving outpatient chemotherapy. Data were collected from the electronic health records and clinical databases of several health care systems in the United States that catered to adult chemotherapy patients experiencing treatment-related psychological distress. Patients were compared based on their receipt of music therapy interventions or their receipt of standard therapy with no psychosocial support. The study’s findings revealed that the outpatient oncology music therapy cohort had significantly lower anxiety levels and that overall emotional wellness was improved, compared to the standard care cohort. The findings of this study imply that music therapy interventions assist chemotherapy patients in emotional self-regulation, stress, and anxiety relief. Evidence to support the use of music therapy in outpatient oncology was provided by this study. The study documented the positive effects of music therapy in reducing outpatient oncology patients’ anxiety and improving the overall wellness of patients in the outpatient oncology setting. Ramón, N. C., Arenillas, J. I. C., Valero, S. A., Guzmán, A. S., & Miralles, P. M. (2023). Psychosocial interventions for the treatment of cancer-related fatigue: An umbrella review. Current Oncology, 30(3), 2954–2977. https://doi.org/10.3390/curroncol30030226 Research/QI: Research Design This paper seeks to summarize the most recent studies, clinical guidelines, and evidence-based recommendations on the use of psychosocial interventions within cancer treatment. Specific clinical research examines the use of either collaborative or individualized music therapy on the psychological state of patients undergoing infusion chemotherapy. Strong evidence was found on the palliative, dose-related effects of music therapy on patients undergoing chemotherapy. Additional evidence showed that patients demonstrated greater engagement and response, especially when music therapy was integrated within the infusion process. Evidence also illustrated the need for music therapy and psychosocial interventions in the framework of outpatient chemotherapy focused on the individual patient. Asakawa, H. K. D., Spiegel, D., Bossert, L., Garic, A., Schwartz, K., Voracek, M., & Tran, U. S. (2026). Psychosocial interventions indicate prolonged survival in cancer patients in a systematic review,

NURS FPX 8004 Assessment 4 Literature Review Student name Capella University NURS- FPX8004 Professor Name Submission Date NURS FPX 8004 Assessment 4 Literature Review Music therapy has been shown to reduce anxiety and improve wellness in adults receiving outpatient chemotherapy. Services in an outpatient oncology infusion center involve the repeated delivery of chemotherapy with little to no non-pharmacologic support. The target population is adult oncology outpatient chemotherapy patients (Executive Nurse, personal communication, April 15, 2026). The PICOT question for this study involves outpatient oncology chemotherapy staff (P). Does the provision of music therapy (I) in comparison to the absence of music therapy (C) result in a beneficial effect on the anxiety and wellness of patients (O)? A literature search through PubMed/MEDLINE, CINAHL, Cochrane, and the like was performed using the terms music therapy and chemotherapy, cancer patients anxiety, oncology music interventions, chemotherapy psychological distress, and outpatient oncology well-being. The search was narrowed to articles in English, published 2022–2026, and the Boolean operator AND. The purpose of this literature review was to analyze the recent research to understand the impact music therapy has in outpatient oncology and the potential it has for a structured non-pharmacologic intervention in this area to reduce adult chemotherapy patients’ anxiety and enhance their sense of well-being. Thematic Synthesis of Literature Theme 1: Music Therapy Outcomes in Chemotherapy Care The effectiveness of supportive nurse interventions for adult oncology patients receiving outpatient chemotherapy has gained substantial research support for improving psychosocial outcomes and decreasing anxiety. In a randomized controlled trial, Ettenberger and colleagues (2025) found that incorporating group music therapy into chemotherapy sessions resulted in a notable decrease in the state of anxiety of chemotherapy patients and an enhancement in their well-being. In a similar line of research, Salgado et al. (2025) found that actively participating in structured music therapy (MT) interventions helped to decrease the stress and treatment side effect levels for patients and their caregivers. Both of the studies cited that structured music therapy helped to regulate emotions during music therapy and increased the well-being and health status of patients during chemotherapy beyond the levels of care that were provided in standard chemotherapy. Overall, the studies concluded that an effective non-pharmacological intervention to decrease anxiety in oncology therapy was music therapy. Despite the plethora of studies documenting the benefits of music therapy for oncology patients, there were a few cases highlighted in the literature. In contrast, Ramón et al. (2023) and Feng & Wang (2023) compiled the same studies and pointed out the psychological and physical benefits, as well as improvements in the quality of life for patients of different oncology populations, in spite of the inconsistency of results for the different program delivery styles. Music-based methods within the cancer care environment, as described by Ramírez et al. (2023), were positively received, and in oncology care, there were consistent enhancements in emotional health and well-being from the work of Feng & Wang (2023). The evidence showed that the consistency and structuring of music therapy would likely be a stronger anxiety-reducing, wellness-enhancing approach and be a more helpful addition than usual care, which lacks psychosocial support. Music therapy, as the evidence shows, holds promise within the field of oncology for patients undergoing chemotherapy and supports having positive emotional outcomes. Theme 2: Structured Music Therapy Programs and Standardized Implementation Some of the sources discussed insist on the importance of systematic music therapy sessions and a systematic and cohesive use of music in the outpatient oncology chemotherapy setting. Asakawa and colleagues (2026) demonstrated that a structured group music therapy intervention decreased anxiety and promoted the psychological well-being of adult chemotherapy patients. Likewise, He et al. (2026) demonstrated that the structured music therapy sessions of patients and caregivers led to a reduction of anxiety, stress, and treatment-related adverse side effects. Together, both studies indicated that music therapy leads to improved emotional regulation during chemotherapy, especially with planned and systematic sessions. Out of the sessions offered, structured music therapy sessions had a greater likelihood to improve patient outcomes compared to informal and non-structured supportive sessions. Standardized intervention models, as discussed by Mertens et al. (2025 and Hernandez et al. (2026, are crucial for designing interventions that integrate music therapy into clinical oncology day unit services and for ensuring that music therapy is relevant and routinely available as part of oncology care. Mertens et al. (2025) emphasized therapist-directed and structured interventions as critical for obtaining consistent and measurable reductions in anxiety, while Hernandez et al. (2026) described interventions that promote sustained positive emotional and mental health and wellness and quality of life improvements. However, the unacceptably high level of variability within everyday oncology care continues to pose a challenge for the integration of structured psychotherapeutic interventions in most clinical settings. Collectively, the studies suggest that within the context of oncology, standardized music therapy during chemotherapy represents an important psychological and emotional resource for care. The overall consensus is that the music therapy interventions as described have great potential for positive psychosocial impact on oncology care. Theme 3: Structural and Relational Barriers to Music Therapy Implementation A third important theme refers to organizational and interpersonal issues that hinder the consistent incorporation of music therapy for outpatient chemotherapy patients. Tsegaye et al. (2023) highlighted the lack of standard supportive care and the absence of formal guidelines, which resulted in inconsistent regular application of non-pharmacological methods in the clinical environment. In a similar vein, Lan et al. (2026) identified the barriers described by patients and professionals, including insufficient staff, scheduling barriers, issues with health insurance, and limited manpower of qualified music therapists. The findings of both studies reflected a critical deficit of music therapy services in the field of oncology due to the level of structuring. Overall, there was a clear absence of formally organized supportive means to achieve a fair and reasonable level of access to psychosocial modalities during chemotherapy. On one hand, barriers to health systems obstruct the timely and efficient provision of support services like music therapy for oncology patients. On

NURS FPX 8004 Assessment 2 Professional Practice Report Student name Capella University NURS- FPX8004 Professor Name Submission Date NURS FPX 8004 Assessment 2 Professional Practice Report The outpatient cardiopulmonary specialty clinic where I currently work is dedicated to treating adult patients with cardiopulmonary related issues. Pulmonary hypertension (PH) is an area of concern for our clinic due to the hyper generalized symptoms of fatigue and shortness of breath. Unfortunately, symptoms of PH are often dismissed or misdiagnosed as other, more common illnesses. These illnesses include bronchial asthma, chronic obstructive pulmonary disease (COPD), or congestive heart failure (Executive Nurse, personal communication, February 15, 2026). Correctly diagnosing PH can take many years, forcing patients to live with a misdiagnosis (Executive Nurse, personal communication, February 15, 2026). There is a general lack of PH awareness among the providers that do the preliminary testing and a general lack of accessible CP and pulmonary testing and referral integration (Executive Nurse, personal communication, February 15, 2026). There is a clear disconnect between the existing evidence based practice (EBP) recommendations for the early recognition of PH and the current practice at the clinic. An important consideration in bridging this gap is the delay in diagnosis of this condition, if any, since it may lead to the progression of the condition and decreased quality of life.  Based on the practice concern, there is a need to do a quality improvement effort to enhance the current practice regarding pulmonary hypertension. This may, then, have far-reaching consequences for the patient and the Health Care Organization. Patients and their families may suffer from worsening symptoms, decreased functional ability, and increased emotional and financial burden due to delayed diagnosis and treatment of the conditions (Kubota et al., 2023). Conversely, healthcare systems can experience a rise in hospitalizations, treatment challenges, and healthcare service utilization of patients who are diagnosed late with pulmonary hypertension (DuBrock et al. 2023). Furthermore, delayed diagnosis can impact the quality benchmarking of the healthcare organization with regards to timely diagnosis, timely treatment, and timely care for patients. One such project could be a quality improvement project aimed at improving the process for identifying pulmonary hypertension early and the effectiveness of referral streamlining to minimize delays in diagnosis and treatment of patients. Problem Statement Pulmonary hypertension is underdiagnosed and/or delayed in the outpatient cardiopulmonary clinic due to limited access to timely specialty evaluation and the inconsistent referral practices. The goal of implementing a quality improvement effort to improve early recognition and diagnosis of PH is to decrease the time to outpatient clinic specialty evaluation of patients with PH symptoms by 25% in 12 weeks of implementation. Thesis Statement The purpose of the quality improvement project is to reduce the time to diagnosis of pulmonary hypertension (PH) by educating providers, coordinating referrals, and implementing interprofessional collaboration within the practice environment. Thus, this approach would result in earlier identification of pulmonary hypertension patients, which would ensure timely access of patients presenting to the outpatient clinic with symptoms of pulmonary hypertension for specialty evaluation. Population The population of the practice site is adult patients >18 years of age, presenting with chronic cardiopulmonary symptoms and clinical suspicion of pulmonary arterial hypertension (PAH). The target patients exhibit symptoms such as increased dyspnea, fatigue, exercise intolerance, dizziness, and/ or chest discomfort. These symptoms warrant additional workups as they may be suggestive of underlying cardiopulmonary pathologies (Executive Nurse, personal communication, February 15, 2026). The population of focus for this quality improvement project are adult patients exhibiting symptoms/ dyspnea of unknown etiology and requiring further diagnostic workup to rule in/ out pulmonary hypertension (Executive Nurse, personal communication, February 15, 2026). Of all the patients who appear in the clinic with dyspnea of unknown origin, the percentage of those whose diagnosis and treatment are delayed is around 35%, and the delay in diagnosis is more than 4 weeks. Furthermore, within the organization, it was found that approximately 28% of people with pulmonary hypertension were not referred to pulmonary hypertension clinics. Adult patients who present to the clinic with cardiopulmonary symptoms and are determined to require specialty care for pulmonary hypertension because of these symptoms are included in the quality improvement initiative. These exclusion criteria would include pediatric patients, patients with a previous diagnosis of advanced pulmonary hypertension who are already receiving specialist care, and patients who are only receiving treatment for other unrelated heart and lung diseases. Another population that would be relevant to the practice change is the healthcare professionals and staff at the practice site who would be involved in the process of change, such as physicians, nurse practitioners, registered nurses, and referral coordinators, who would evaluate symptoms, order tests for patients, and assist with referrals to specialists for pulmonary hypertension. Stakeholders At the outpatient cardiopulmonary specialty clinic, there are several key stakeholders that are involved in addressing the practice issue of delayed diagnosis/referral for pulmonary hypertension. Main stakeholders include healthcare professionals who assess and manage patients with cardiopulmonary complaints and who make referrals for pulmonary hypertension. These include Physicians, Nurse Practitioners, Registered Nurses, and Respiratory Therapists. Stakeholders also include employees in healthcare organizations at the managerial level, particularly those responsible for managing and leading quality improvement teams. These employees are responsible for the operational aspects of quality and safety compliance (Spitzer et al., 2022). The stakeholders impacted by the practice problem – patients and families – who are likely to suffer from lower quality of life and poorer health outcomes due to the lack of timely diagnosis and treatment of pulmonary hypertension. There are different concerns for each stakeholder group that must be considered. The providers would probably be more interested in ensuring the efficiency of work and would be resistant to anything that would make the job more complicated, such as additional documentation or referrals, so communications should focus on simplicity and benefits for patients. Information should be provided in terms of the outcomes and efficiency of patient care as it relates to performance measures and costs, to those who have leadership roles in

NURS FPX 8004 Assessment 1 Professional Practice Report Student name Capella University NURS- FPX8004 Professor Name Submission Date Section I: Application of the MEAL Plan As pressure in the arteries that move the blood from the heart to the lungs rises, the blood is not able to flow through them, and they cannot be as effective at delivering oxygen to the body—this is called pulmonary hypertension (PH) and can also result in poor health outcomes. (E) This condition can be associated with a number of underlying disorders, including conditions affecting the lungs, heart, and liver, and is associated with connective tissue disorders and some chronic infections. While the PH can happen to people of all ages more often seen in people with autoimmune diseases, those living at high altitudes, and those with congenital heart problems. While still hard to detect early, better management is difficult, but reducing the susceptibility by modifying other risk factors, such as systemic hypertension, chronic respiratory diseases, and smoking, is possible. There is no cure; the treatment consists of treating the symptoms with pharmacologic treatments, supplemental oxygen and diuretics. The level of public awareness and understanding, early diagnosis, and specific management strategies will be essential to improving the outcomes and Quality of Life of individuals with the PH issue. Summary of Scholarly Source The PH is serious and may be life threatening, and intensive clinical management and monitoring are needed. Despite the effectiveness of treatments, the results have been less than optimal, particularly when PH is associated with other chronic conditions. Klinger et al. (2023) carried out a retrospective cohort study to understand the clinical and economic impact of PH in patients with chronic obstructive pulmonary disease (COPD) between 2016 and 2021 from the Optum® Clinformatics® Data Mart. PH-COPD patients were matched with COPD patients who did not have PH, and a total of 1,627 patients were included in the study. The results revealed a significant increase in exacerbation rates (in terms of either the number or severity of exacerbations) and a reduced time to first exacerbation in the persons with PH-COPD. In addition, the rate of hospitalizations and outpatient use, as well as emergency department (ED) visits, were all higher. Besides, the disease was also an economic burden since the health care costs associated with PH-COPD patients and with COPD itself were significantly higher when compared with patients without PH-COPD. This study showed the importance of PH in the clinical and economic burden of COPD patients and supported the fact that the population of patients with PH and COPD is a patient population with no specific treatment. Section II: Practice Site and Problem The practice is a cardiovascular/pulmonary specialty in the southern United States and is a large academic medical center. It has an intensive care unit (ICU) with high acuity care as well as outpatient clinics to treat complex conditions, such as pulmonary hypertension. There are advanced programs for cardiopulmonary diagnostics, pharmacologic therapy, and research to further improve patient outcomes. For patients with severe cardiopulmonary disease, such as those with pulmonary hypertension (PH), there is a correlation between better outcomes as patients, better care coordination, and better adherence to evidence-based guidelines for those receiving high acuity care in an intensive care unit (ICU) with outpatient specialist care (Espelta et al., 2023). The center serves a diverse population, including disadvantaged sectors, for whom access and receipt of medical care are fraught with a variety of problems. At the personal communication level, executive leadership confirms that the evidence-based care of physician, nurse, and respiratory therapy (RT) interdisciplinary teams is well supported, at which point right heart failure occurs, and pulmonary hypertension (PH) is a progressive condition that causes an increase in pulmonary artery pressure. The problems in the ICU are exacerbated by those of critically ill patients. Currently, no uniform screening/testing method or treatment protocols have been established. There is a lack of understanding of PH among staff, and care is fragmented. The university is organized according to the layered management system, which can play a supporting role in collaboration between the disciplines, as well as continuous improvement of quality. Innovation, inclusiveness, and the use of evidence based practice are aimed at helping reduce the health care gap to facilitate health equity. In a health care system, the focus on quality is about the standardization of the taking of care processes and minimization of the risk of “iatrogenic” injuries. Identification of the Problem From the practice setting, patient reported outcome measures (PROMs) and staff comments revealed the following issues related to a delay in the diagnosis and variable management of PH: (1) difficulties with recognition, (2) burden of the disease (physical and mental), and (3) issues related to treatment. During the period of January 2023 to March 2024, 39% of all the patients with PH were in the critically ill group, where the delay of diagnosis was more than 20% (it is important to note that this diagnostic delay is at least 2 times more than the international benchmark suggested by the American Thoracic Society in 2024). The data revealed that those diagnosed later were, on average, in the ICU for 9.2 days while those diagnosed timely were in the ICU for 5.6 days. Not having a standardized screening tool for the ICUs and not having a uniform application of evidence-based interventions were identified as a concern by the nursing staff (personal communication, Executive Nurse, 15th April 2026). The lack of practices is a significant missed opportunity to either timely identification of children at risk and/or proper treatment of children. While multidisciplinary team management is encouraged in American Thoracic Society (ATS) and European Respiratory Society (ERS) guidelines, it is recognized that practices with such functionality aren’t necessarily in place (ATS, 2024). This is not an isolated problem, as the mean of less than 30% of patients arriving in an ICU with PH receive the correct treatment in the first 48 hours after the start of PH treatment (Zuin, 2024). A delay in diagnosis has been